-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
-
Summary
-
Allogene Therapeutics, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q4 2017 to Q3 2024.
- Allogene Therapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending September 30, 2024 was 10M shares, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)